Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.27B |
| 2 |
Blackrock
BLK
|
+$1.21B |
| 3 |
PG&E
PCG
|
+$1.17B |
| 4 |
Alibaba
BABA
|
+$1.12B |
| 5 |
T-Mobile US
TMUS
|
+$826M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$1.34B |
| 2 |
Boston Scientific
BSX
|
+$1.26B |
| 3 |
American Express
AXP
|
+$1.23B |
| 4 |
GE Aerospace
GE
|
+$1.1B |
| 5 |
Visa
V
|
+$993M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Healthcare | 16.37% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.24% |
| 5 | Communication Services | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Ventas
VTR
$47.7B
| $406M | 0.04% |
11,076,762
+635,108
| +6% | +$21M |
|
|
HZNP
377
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $405M | 0.04% |
7,288,468
+1,317,555
| +22% | +$56.4M |
|
|
RDS.A
378
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $403M | 0.04% |
12,319,088
-69,075
| -0.6% | -$2.37M |
|
379
iShares Core MSCI EAFE ETF
IEFA
$196B
| $402M | 0.04% |
7,036,485
-11,436,950
| -62% | -$620M |
|
380
ITT
ITT
$19.3B
| $398M | 0.04% |
6,779,718
+1,218,406
| +22% | +$64.6M |
|
381
TransDigm Group
TDG
$68.3B
| $395M | 0.04% |
893,746
-101,590
| -10% | -$38.4M |
|
|
CTXS
382
DELISTED
Citrix Systems Inc
CTXS
| $391M | 0.04% |
2,644,032
-194,120
| -7% | -$27.9M |
|
383
Phillips 66
PSX
$82B
| $391M | 0.04% |
5,433,023
-160,070
| -3% | -$11.3M |
|
384
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.7B
| $384M | 0.04% |
7,153,910
-2,367,727
| -25% | -$119M |
|
385
BP
BP
$108B
| $383M | 0.04% |
16,411,369
-2,938,681
| -15% | -$70.5M |
|
386
VeriSign
VRSN
$26.5B
| $380M | 0.04% |
1,835,864
+179,099
| +11% | +$37.2M |
|
387
Tapestry
TPR
$33B
| $379M | 0.04% |
28,550,318
+5,136,901
| +22% | +$72.9M |
|
388
Healthcare Realty
HR
$6.89B
| $376M | 0.04% |
14,187,830
+1,439,572
| +11% | +$36.9M |
|
389
Canadian National Railway
CNI
$77.1B
| $375M | 0.04% |
4,242,664
+154,000
| +4% | +$12.8M |
|
390
Highwoods Properties
HIW
$3.51B
| $374M | 0.04% |
10,026,351
+2,866,594
| +40% | +$107M |
|
391
Helen of Troy
HELE
$690M
| $374M | 0.04% |
1,982,891
-294,135
| -13% | -$48.1M |
|
|
SBNY
392
DELISTED
Signature Bank
SBNY
| $373M | 0.04% |
3,490,699
+1,075,297
| +45% | +$106M |
|
|
ONEM
393
DELISTED
1Life Healthcare
ONEM
| $373M | 0.04% |
10,495,698
+986,136
| +10% | +$27.8M |
|
394
Royal Bank of Canada
RY
$293B
| $372M | 0.04% |
5,476,492
+1,002,340
| +22% | +$63.7M |
|
395
CSX Corp
CSX
$94B
| $372M | 0.04% |
15,981,147
+1,358,457
| +9% | +$30.1M |
|
396
Allstate
ALL
$67.8B
| $371M | 0.04% |
3,829,334
-768,271
| -17% | -$75.5M |
|
397
NNN REIT
NNN
$8.99B
| $370M | 0.04% |
10,440,266
+3,004,791
| +40% | +$98.3M |
|
398
Philip Morris
PM
$295B
| $370M | 0.04% |
5,285,710
-6,000,095
| -53% | -$437M |
|
399
Bio-Rad Laboratories Class A
BIO
$9.28B
| $368M | 0.04% |
815,833
+84,608
| +12% | +$37.3M |
|
400
Entergy
ETR
$50.3B
| $366M | 0.04% |
7,797,636
-1,472,642
| -16% | -$71.5M |
|
Similar funds
Fidelity Investments's Q2 2020 Portfolio in Review
As of Q2 2020, Fidelity Investments held 4,490 positions worth $909B, up 26% from $722B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fidelity Investments's Q2 2020 filing shows 334 new, 1,365 increased, 1,743 reduced and 502 closed positions. Its largest new stake was Royalty Pharma: 16,356,491 shares worth $743M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2020 buy was Royalty Pharma: 16,356,491 shares worth $743M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q2 2020, an estimated $2.27B increase.
- Fidelity Investments's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.34B.
- Fidelity Investments fully exited Sprint Corporation in Q2 2020, selling an estimated $225M.
- Fidelity Investments's ten largest holdings make up 28% of its $909B portfolio in Q2 2020.
- Fidelity Investments opened 334 new positions and closed 502 in Q2 2020.
- Fidelity Investments's portfolio value rose 26% quarter-over-quarter to $909B.
Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.